The highest resolution snapshots yet showing how bacteria adapt to survive treatment with quinolone drugs are giving drug makers an additional weapon in the fight against antibiotic resistance. Scientists at King's College London and St. George's, University of London, have shown exactly how quinolones, which are the second line of defence against diseases like pneumonia and meningitis, interact with their topoisomerase IV enzyme target. The researchers captured detailed crystal structures using high power x-rays produced at the Diamond synchrotron in the UK and its French counterpart, Soleil. From these images the team has been able to identify the amino acids that mutate...